Industry Expert in Japan with an MD
Patient-Centric Approach
The Patientricity Way
Patient + Centricity = Patientricity
Helping biopharma transform
their business in Japan
one patient group at a time
We envision a society
where no one patient gets left behind
Market Challenges
While Japan is recognized as being one of the most advanced healthcare systems in the world that offer universal coverage, there are many examples where innovation has been stifled and available treatment options are surprisingly limited, especially in rare diseases and certain cancer types. Unfortunately, some of these gaps are increasing, with the end result being that not everyone has equal access to the ideal treatments.
Patientricity aims to close the gap in patient access by making innovative medicines available to patients in Japan and helping patients have an improved quality of life. We believe that in order to close the gap between the ideal treatments and the realities of today, companies would benefit in taking a more patient-centric approach in identifying needs and designing solutions.
On Founding Patientricity
As a physician, I saw and treated patients on a daily basis. That changed when I started my ‘second’ career in the pharmaceutical industry, as I no longer had the chance to interact with patients.
Throughout my industry years, I observed firsthand situations where the needs of patients and
their families were not always fully understood by the company, which had to rely on an external
network of practicing physicians to glean related insights. In the process, I came to realize an
opportunity for me to help bridge that gap — and from this realization, Patientricity was born.
If medicines (solutions) are developed to tackle diseases (issues) as intended, then it is essential
for pharmaceutical companies to listen to and talk with not only healthcare professionals, but also
with the very patients suffering from the ailments they seek to treat as well as their families.
I believe that better drug development and related services can only be achieved by incorporating
these understandings and the wishes of patients while ensuring they have a voice in this process
and are duly engaged.
In founding Patientricity, I have had the good fortune to resume my practice part-time; each week I now see roughly 25 patients with a variety of common diseases and disabilities, including hypertension, diabetes, chronic kidney diseases, common skin problems and dementia. In this dual capacity, my vision is to contribute to the transformation of the pharmaceutical industry in Japan toward an increasingly patient-centric model that not only engages patients better, but also serves them, and thereby society better.
_JPG.jpg)